Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2008
10/02/2008WO2008117079A1 Antimicrobial compounds based upon 4-aminoquinoline
10/02/2008WO2008117061A2 Tetrahydroisoquinolines as tumour growth inhibitors
10/02/2008WO2008117051A1 S-6-meth0xy-2- (2- (3- (pyrimid-2-yl) is0xaz0l-5-yl) pyrrolidin-1-yl) -4- (5-methyl-ih-pyrazol-s-ylamino) pyrimidine and polymorphic forms thereof as modulators of the insulin-like growth
10/02/2008WO2008117050A1 Pyrazolyl-amino-substituted pyrazines and their use for the treatment of cancer
10/02/2008WO2008117047A1 Pyrazolo[3, 4-d]pyrimidine derivatives as antibacterial compounds
10/02/2008WO2008117046A1 Pyrazolo [4, 3-d] pyrimidines as antibacterial compounds
10/02/2008WO2008117018A2 A tablet having improved stability with at least two actives
10/02/2008WO2008116959A1 Use of maslinic acid and derivatives thereof for treatment of diseases connected with elastase inhibition, such as neuromas, erythemas, sun and heat burns, and psoriasis
10/02/2008WO2008116926A1 Tetrahydroindole derivatives as nadph oxidase inhibitors
10/02/2008WO2008116920A2 17beta-hydroxysteroid-dehydrogenase type 1 inhibitors for the treatment of hormone-dependent diseases
10/02/2008WO2008116919A1 Pharmaceutical composition comprising a cytokine
10/02/2008WO2008116914A1 Purinyl derivatives and their use as potassium channel modulators
10/02/2008WO2008116911A1 Purinyl derivatives and their use as potassium channel modulators
10/02/2008WO2008116910A1 Purinyl derivatives and their use as potassium channel modulators
10/02/2008WO2008116909A1 Purinyl derivatives and their use as potassium channel modulators
10/02/2008WO2008116898A1 Pyrazolo [1,5-a]pyrimidines as inhibitors of stearoyl-coa desaturase
10/02/2008WO2008116890A2 Pharmaceutical compositions comprising flibanserin and a further agent in the treatment of sexual disorders
10/02/2008WO2008116881A1 Substituted pyrrolidine amides, the production thereof, and the use thereof as medications
10/02/2008WO2008116873A1 Oral contraceptive regimen
10/02/2008WO2008116845A1 Piperidinone carboxamide derivatives as p2x7 modulators
10/02/2008WO2008116833A1 Azetidin compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
10/02/2008WO2008116831A1 Quinoline compounds suitable for treating didorders that respond to modulation of the serotonin 5-ht6 receptor
10/02/2008WO2008116825A2 Compositions and method for treating pediatric hypogonadism
10/02/2008WO2008116816A1 Combination of cb2 ligand and paracetamol
10/02/2008WO2008116814A1 Pyrrole and isoindole carboxamide derivatives as p2x7 modulators
10/02/2008WO2008116813A2 Combination medicaments for treating bacterial infections
10/02/2008WO2008116809A1 Pharmaceutical compositions comprising a bisphosphonate and vitamin d
10/02/2008WO2008116742A1 Aza-pyridopyrimidinone derivatives
10/02/2008WO2008116671A1 2,3,4,9-tetrahydro-1h-carbazoles
10/02/2008WO2008116670A1 Novel 5-cyano-prostacyclin derivatives and their use as agents for the treatment of autoimmune diseases
10/02/2008WO2008116669A1 Novel 5-cyano-prostacyclin derivatives and their use as agents for the treatment of influenza a viral infection
10/02/2008WO2008116665A1 Substituted imidazopyridine derivatives as melanocortin-4 receptor antagonists
10/02/2008WO2008116663A2 Heterocyclyl-substituted-tetrahydro-naphthalen-amine derivatives, their preparation and use as medicaments
10/02/2008WO2008116641A2 Oleyl phosphocholine
10/02/2008WO2008116620A1 8-oxy-quinoline derivatives as bradykinin b2 receptor modulators
10/02/2008WO2008116602A1 Cosmetic preparations designed to reduce unsightly cellulite
10/02/2008WO2008116601A2 Solid dosage forms comprising aliskiren and pharmaceutically acceptable salts thereof
10/02/2008WO2008116391A1 The neuroblast proliferation promoter and the neurite outgrowth promoter
10/02/2008WO2008116385A1 Caffeoyl quinic acid derivatives containing nitrogen, and preparation method, pharmaceutically composition and usage thereof
10/02/2008WO2008116321A1 Allyl sulfide compounds, and compositions and methods using said compounds for repelling blood-feeding arthropods
10/02/2008WO2008116308A1 Quinolone and tetrahydroquinoline and related compounds having nos inhibitory activity
10/02/2008WO2008116304A1 Naphthalene and quinoline sulfonylurea derivatives as ep4 receptor antagonists
10/02/2008WO2008116302A1 Cathepsin cysteine protease inhibitors
10/02/2008WO2008116301A1 Fluorinated derivatives of deferiprone
10/02/2008WO2008100618A3 Carbon-linked tetrahydro-pyrazolo-pyridine modulators of cathepsin s
10/02/2008WO2008099091A3 Use of ivabradine for obtaining drugs for treating endothelial dysfunction
10/02/2008WO2008099076A3 Substituted n-(4-cyano-1h-pyrazol-3-yl)methylamine derivatives, preparation thereof and therapeutic use thereof
10/02/2008WO2008099025A3 Body-weight maintenance and body composition
10/02/2008WO2008098955A3 Antibacterial combination of a tricyclic carbapenem and an antibiotic
10/02/2008WO2008097897A3 Pharmaceutical compositions containing substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1(pai-1)
10/02/2008WO2008097640A3 Triazole compounds that are useful in the treatment of proliferative disorders, such as cancer
10/02/2008WO2008097539A3 Multi-modal absorption, medicine-delivery lozenge, and use thereof
10/02/2008WO2008097483A3 Methods for preparing aryl-substituted ketophosphonates
10/02/2008WO2008094825A3 Compositions and methods for maintaining, strengthening, improving or promoting eye health
10/02/2008WO2008094507A3 Novel fusion compounds
10/02/2008WO2008094484A3 Pharmaceutical compositions and methods of using temozolomide and multi-targeted kinase inhibitors
10/02/2008WO2008093360A3 A process for preparation of (s)-(+)-n-methyl-3(1-naphthyloxy)-3(2-thienyl)propylamine hydrochloride
10/02/2008WO2008093075A3 5,6,7,8-tetrahydropteridine derivatives as hsp90 inhibitors
10/02/2008WO2008093024A3 N-(amino-heteroaryl)-1h-pyrrolopyridine-2-carboxamides derivatives, preparation thereof and their use in therapy
10/02/2008WO2008092954A3 Polymorphic forms of a macrocyclic inhibitor of hcv
10/02/2008WO2008092877A3 8-oxa-1, 4-diazaspiro [4,5] dec-3-en-1-yl and 1,4, 8-triazaspiro [4,5] dec- 3-en-1-yl acetamides as glyti transporter inhibitors in treatment of neurological and neuropsychiatric disorders
10/02/2008WO2008090209A3 Use of glucopyranosyloxy- pyrazoles for preventing and treating neurodegenerative disorders
10/02/2008WO2008086612A8 Hat acetylation promoters and uses of compositions thereof in promoting immunogenicity
10/02/2008WO2008084223A3 Chemical compounds 637: pyridopyrimidinediones as pde4 inhibitors
10/02/2008WO2008082948A3 Ophthalmic alginate composition related methods of manufacture and methods of use
10/02/2008WO2008082490A3 Novel jnk inhibitors
10/02/2008WO2008082369A3 Use of coenzyme q10 for improved effectiveness of animal husbandry and production of animal tissues with an increased content of the said coenzyme
10/02/2008WO2008080015A3 Compounds and methods for kinase modulation, and indications therefor
10/02/2008WO2008079873A3 Thiazolyl compounds useful as kinase inhibitors
10/02/2008WO2008079363A3 Substituted tetracycline compounds for treatment of inflammatory skin disorders
10/02/2008WO2008076918A3 Anti-cancer agents and androgen inhibition activity compound
10/02/2008WO2008075068A3 Acylaminopyrazoles as fgfr inhibitors
10/02/2008WO2008075048A3 Polyalkyloxydibenz ( c, e) oxepine derivatives as medicaments
10/02/2008WO2008074755A3 Novel cinnamic amide derivatives useful as ion channel modulators
10/02/2008WO2008073958A3 Substituted benzothiadiazinedioxide derivatives and methods of their use
10/02/2008WO2008073752A3 Cyclobutyl derivatives for the treatment of glaucoma
10/02/2008WO2008073282A3 Ph sensitive matrix formulation
10/02/2008WO2008073142A3 Novel inhibitors of beta-lactamase
10/02/2008WO2008072954A3 Liposomes containing a polyphenol derivative such as caffeic acid and a method of post-loading thereof
10/02/2008WO2008071456A3 3-h-pyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
10/02/2008WO2008070402A3 Intraocular drug delivery systems
10/02/2008WO2008070009A3 Treating solid tumors and monocytic leukemia using topoisomerase inhibitors in liposomes
10/02/2008WO2008067995A3 Means and method for raising improved immune response
10/02/2008WO2008067781B1 A method of purification of (s)-n-methyl-3-(1-naphtyloxy)-3-(2-thienyl) propylamine hydrochloride (duloxetine)
10/02/2008WO2008067120A3 (s)-phenyl(heterocycle)methanol-based compounds, compositions comprising them and methods of their use
10/02/2008WO2008065370A3 Sesquiterpenoid modifying enzymes
10/02/2008WO2008064866A8 Treatment for multiple myeloma
10/02/2008WO2008064321A3 Methods of treating chronic inflammatory diseases using a gm-csf antagonist
10/02/2008WO2008064217A3 Crystal forms of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol and pharmaceutical formulations thereof
10/02/2008WO2008063563B1 Methods of treating keratin hyperproliferation disorders using mtor inhibitors
10/02/2008WO2008062167A3 Melatonin derivatives and their use as antioxidants
10/02/2008WO2008060362A3 Methods and compositions for the treatment of skin diseases and disorders
10/02/2008WO2008059518A3 Process for preparing crystalline aripiprazole
10/02/2008WO2008058235A3 Processes for the preparation of cinacalcet
10/02/2008WO2008057867A3 Sustained release drug delivery systems comprising a water soluble therapeutic agent and a release modifier
10/02/2008WO2008057604A9 Small molecule therapeutics, syntheses of analogues and derivatives and methods of use
10/02/2008WO2008057464A3 Compositions and methods for improving the bioavailability of liothyronine
10/02/2008WO2008057402A3 N-aryl-isoxazolopyrimidin-4-amines and related compounds as activators of caspases and inducers of apoptosis and the use thereof
10/02/2008WO2008057283A3 Use of resolvins for inhibition of bone loss
10/02/2008WO2008053194A3 Pyridine carboxamides as 11-beta-hsd1 inhibitors
1 ... 3059 3060 3061 3062 3063 3064 3065 3066 3067 3068 3069 3070 3071 3072 3073 3074 3075 3076 3077 3078 3079 ... 7860